Upon reviewing the literature, we have collectively validated five co-upregulated DEGs (DGAT1, AMOT, PDE11A, TYMS, and TMEM98) that were elevated in patients with AF, NAFLD, and in those with NAFLD-related AF compared to the HC group. Here, PDE11A is linked to metabolic dysfunction-associated steatotic liver disease.